News | April 22, 2009

HRS Reiterates Positive Correlation Between EP Certification, Improved ICD Outcomes

April 22, 2009 – In response to the article “Association of Physician Certification and Outcomes Among Patients Receiving an Implantable Cardioverter-Defibrillator,” published in the April 22 issue of the JAMA, the Heart Rhythm Society reiterates its position on the positive correlation between electrophysiology certification and improved outcomes following ICD implantation.

The study used cases submitted to the ICD Registry, which was created by the Heart Rhythm Society and the American College of Cardiology Foundation to collect detailed information on ICD implantations to assess and improve the care of patients receiving ICDs for primary prevention therapy.

The authors compared patient outcomes based on the certification status of the implanting physician: electrophysiologist, non-electrophysiologist cardiologist, thoracic surgeon and other specialists. Overall implantations by a non-electrophysiologist were associated with a higher risk of procedural complications compared to ICDs implanted by an electrophysiologist. Patients of non-electrophysiologists were also less likely to receive a CRT-D device when indicated compared to patients of electrophysiologists.

“This important study confirms the Society’s position that trained and experienced electrophysiologists are best equipped to provide optimal care for patients who need life-saving ICD or CRT-D therapy,” said N.A. Mark Estes, president of the Heart Rhythm Society. “Specialized training enables physicians to not only implant devices with a lower risk of procedural complications, but also select the most appropriate device-based therapy for each patient.”

The analysis also examined the geographic distribution of ICD implants, and found that the majority of ICD implants performed by nonelectrophysiologists took place at or relatively near hospitals in which an electrophysiologist also implanted ICDs.

The Heart Rhythm Society strongly recommends that all physicians and credentialing bodies follow the training guidance found in the ACC/ACP/AHA/HRS Recommendations for Training in Adult Cardiovascular Medicine Core Cardiology Training (COCATS) 3: Task Force 6 Training in Specialized Electrophysiology, Cardiac Pacing, and Arrhythmia Management.

For more information:,

Related Content

The FDA is concerned about cybersecurity of ICDs and cyber security of other medical devices.
Feature | Cybersecurity| August 16, 2017 | Dave Fornell
There is growing concern among patients and regulators that medical devices, especially implantable electrophysiology
Three New Atrial Fibrillation Studies to Feature HeartLight Endoscopic Ablation System
News | Ablation Systems| August 07, 2017
CardioFocus Inc. announced that its HeartLight Endoscopic Ablation System is being featured in three new major clinical...
Merge Hemo cath lab hemodynamics monitoring system.

Hemodynamic data shown on screens from the Merge Hemo recording system. It is among the newer generation hemodynamic systems for cath labs that are more user friendly and have technologies to speed workflow.

Feature | Hemodynamic Monitoring Systems| August 03, 2017 | Dave Fornell
The current generation of...
Left Atrial Pressure Monitor from Vectorious Medical Technologies Offers New Hope for Heart Failure Patients

On of the top stories in July was the introduction of a left atrial pressure monitor from Vectorious Medical Technologies to prevent heart failure patient hospitalizations or readmissions. Read the article"Left Atrial Pressure Monitor Offers New Hope for Heart Failure Patients."

Feature | August 01, 2017 | Dave Fornell
Ohio State Researchers Prove Human Heart's 'Battery' Has Multiple Backups
News | EP Lab| July 27, 2017
July 27, 2017 — There is good news when it comes to the heart’s sinoatrial node (SAN), the body’s natural...
Medtronic Announces First Enrollments in STOP AF First Clinical Trial
News | Ablation Systems| July 24, 2017
Medtronic plc recently announced first enrollments in the STOP AF First clinical trial. The trial will evaluate the...
Biotronik Launches DX Technology for U.S. Heart Failure Patients
News | Cardiac Resynchronization Therapy Devices (CRT)| July 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and availability of the Intica DX and Intica...
Cardiologs ECG Analysis Platform Receives FDA Clearance
Technology | ECG Monitoring Services| July 13, 2017
Cardiologs Technologies SAS announced that it has received U.S. Food and Drug Administration (FDA) clearance of its...
Overlay Init